PacBio logo.jpg
PacBio and ARUP Laboratories Collaborate in a Study to Improve Rare Disease Diagnosis
November 18, 2021 09:00 ET | Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Nov. 18, 2021 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, and ARUP Laboratories announced today they are...
CENTOGENElogo.jpg
CENTOGENE Initiates EFRONT Study to Identify Patients With Genetic Forms of Frontotemporal Dementia
June 02, 2021 06:31 ET | CENTOGENE GmbH
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, June 02, 2021 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on generating data-driven insights to diagnose,...
CENTOGENElogo.jpg
CENTOGENE Launches NEW CentoXome® - An Enhanced Whole Exome Sequencing Solution
June 01, 2021 06:30 ET | CENTOGENE GmbH
World leader and trusted partner in rare diseases releases enhanced Whole Exome Sequencing (WES) solution to improve diagnosis in complex and unsolved patient casesNEW CentoXome® provides...
Ovation Fertility Releases Preliminary Findings of Ongoing Non-Invasive PGT-A Study
February 28, 2021 14:00 ET | Ovation Fertility
Los Angeles, Feb. 28, 2021 (GLOBE NEWSWIRE) -- Ovation® Fertility’s Genetics program has released the initial findings of its ongoing study of non-invasive preimplantation genetic testing for...
CENTOGENElogo.jpg
CENTOGENE Expands Partnership with PTC Therapeutics to Generate New Insights for Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency
November 25, 2020 06:30 ET | CENTOGENE GmbH
CAMBRIDGE, Mass. and ROSTOCK, Germany and HEIDELBERG, Germany and BERLIN, Nov. 25, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that...
Ovation Research Accepted for Presentation at ASRM 2020
October 20, 2020 11:00 ET | Ovation Fertility
Los Angeles, Oct. 20, 2020 (GLOBE NEWSWIRE) -- Ovation® Fertility is once again proving its status as a prolific producer of research in the field of reproductive medicine, with six abstracts...